AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Arkansas’ own statistics show much work to be done. Per a 2023 press release from the Arkansas Department of Health, nearly ...
Women and younger Americans are being diagnosed with cancer more than ever before, according to a new report published by ...
Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Young women are nearly twice as likely to be diagnosed with cancer as young men. Breast and thyroid cancers are significant ...
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.
Rates of breast and thyroid cancer for women under 50 rose from 2002 to 2021, while men in the same age group had declining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback